デフォルト表紙
市場調査レポート
商品コード
1425504

ゲノム編集/ゲノム工学の世界市場レポート 2024年

Genome Editing/Genome Engineering Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円
ゲノム編集/ゲノム工学の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

ゲノム編集/ゲノム工学の市場規模は近年急速に拡大しています。2023年の72億3,000万米ドルから2024年には85億7,000万米ドルへと、CAGR18.6%で成長します。過去の期間に観察された成長は、遺伝学とゲノミクスの研究増加、遺伝性疾患の増加、遺伝子治療の進歩、バイオテクノロジーと生命科学への多額の投資、農業への応用の可能性、モデル生物における遺伝子研究の活用に起因しています。

北米は、2023年のゲノム編集またはゲノム工学市場において最大の地域でした。アジア太平洋は、予測期間中、ゲノム編集/ゲノム工学市場レポートにおいて最も急成長する地域となる見込みです。ゲノム編集/ゲノム工学市場レポートでカバーされている地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のゲノム編集/ゲノム工学市場の促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のゲノム編集/ゲノムエンジニアリングの市場規模の実績と成長、2018年から2023年
  • 世界のゲノム編集/ゲノム工学市場規模と成長予測、2023年から2028年、2033年

第6章 市場セグメンテーション

  • 世界のゲノム編集/ゲノム工学市場、製品およびサービス別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 試薬と消耗品
  • ソフトウェアとシステム
  • サービス
  • 世界のゲノム編集/ゲノム工学市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • CRISPR
  • TALEN
  • ZFN
  • アンチセンス
  • その他の技術
  • 世界のゲノム編集/ゲノム工学市場、アプリケーション別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 細胞株工学
  • 遺伝子工学
  • 診断アプリケーション
  • 創薬と開発
  • その他の用途
  • 世界のゲノム編集/ゲノム工学市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • バイオテクノロジー企業
  • 製薬会社
  • 学術および政府の調査機関

第7章 地域および国の分析

  • 世界のゲノム編集/ゲノム工学市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のゲノム編集/ゲノム工学市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ゲノム編集/ゲノム工学市場の競合情勢
  • ゲノム編集・ゲノム工学市場企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Merck Group
    • Genscript Biotech Corp
    • Sangamo Therapeutics Inc.
    • Lonza Group AG

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12735

Genome Editing/Genome Engineering Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genome editing/genome engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genome editing/genome engineering? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genome editing/genome engineering market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product And Service: Reagents And Consumables; Software And systems; Services
  • 2) By Technology: CRISPR; TALEN; ZFN; Antisense; Other Technologies
  • 3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development; Other Applications
  • 4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck Group; Genscript Biotech Corp; Sangamo Therapeutics Inc.; Lonza Group AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Genome editing is a technique that allows scientists to modify the DNA of various organisms, including plants, bacteria, and animals. This technology enables the alteration of DNA, influencing physical characteristics such as eye color and the susceptibility to diseases. Genome editing is extensively used in research labs with animal models and cells to gain insights into diseases.

The main products and services in genome editing and genome engineering encompass reagents and consumables, software and systems, and services. Reagents and consumables are utilized at specific locations in the genome of a target organism to induce breaks, repairs, or mismatches, leveraging endogenous mechanisms to bring about specific changes in the DNA sequence. Consumables are items used until depletion and then disposed of, while reagents are compounds or substances that facilitate a reaction. Various technologies, including Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nucleases (ZFN), antisense, and others, are employed in genome editing. These technologies find applications in cell line engineering, genetic engineering, diagnostic applications, drug discovery and development, and various other fields. The users of genome editing technologies include biotechnology companies, pharmaceutical companies, academic and government research institutes.

The genome editing or genome engineering market research report is one of a series of new reports from The Business Research Company that provides genome editing or genome engineering market statistics, including genome editing or genome engineering industry global market size, regional shares, competitors with a genome editing or genome engineering market share, detailed genome editing or genome engineering market segments, market trends and opportunities, and any further data you may need to thrive in the genome editing or genome engineering industry. This genome editing or genome engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genome editing or genome engineering market size has grown rapidly in recent years. It will grow from $7.23 billion in 2023 to $8.57 billion in 2024 at a compound annual growth rate (CAGR) of 18.6%. The growth observed in the historical period can be attributed to the increasing research in genetics and genomics, the rise in genetic diseases, advancements in gene therapy, substantial investments in biotechnology and life sciences, the potential for agricultural applications, and the utilization of genetic research in model organisms.

The genome editing or genome engineering market size is expected to see rapid growth in the next few years. It will grow to $17.16 billion in 2028 at a compound annual growth rate (CAGR) of 18.9%. The anticipated growth in the forecast period can be attributed to the emergence of prime editing, a heightened focus on ethical and regulatory frameworks, an increasing adoption in drug discovery, the therapeutic potential for genetic disorders, customization for gene function studies, and a growing interest in epigenome editing. Major trends expected in the forecast period include advancements in CRISPR technology, the expanding applications in therapeutics, the emergence of new genome editing tools, increased investments and partnerships, the development of enhanced delivery systems, and the integration of artificial intelligence (AI) in genome editing design.

The genome editing or genome engineering market is poised for substantial growth, driven by the increasing prevalence of cancer and other genetic disorders. Genome editing plays a crucial role in addressing these conditions by enabling the rapid engineering of immune cells and oncolytic viruses for therapeutic applications in cancer treatment. With cancer being a leading cause of death worldwide, responsible for nearly 10 million deaths, and a considerable number of new cancer cases reported in the United States, the demand for advanced genome editing technologies is escalating. As such, the rise in the prevalence of cancer and genetic disorders is a key factor propelling the growth of the genome editing or genome engineering market.

The genome editing or genome engineering market is experiencing growth due to the surge in research activities. Research, which involves systematic efforts to gather, analyze, and generate new knowledge, has seen a significant boost with the integration of genome editing technologies. These tools have become instrumental in scientific exploration, offering researchers unparalleled precision and versatility in modifying and understanding the genetic makeup of organisms. The substantial increase in research and development (R&D) spending, reaching $717 billion in the U.S. in 2020 and estimated to further increase to $792 billion in 2021, underscores the pivotal role of genome editing in driving research advancements. Therefore, the market growth is propelled by the increasing adoption of genome editing technologies in various research endeavors.

The genome editing or genome engineering market is witnessing a key trend in technological advancements in gene editing. Major companies are focusing on developing innovative technology solutions to enhance their position in the market. For instance, researchers at Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra) have introduced a novel gene-editing method called Direct Parental CRISPR (DIPA-CRISPR). This technique offers a quick and effective means of editing genes in insects by injecting materials into developing eggs in female adults, bypassing the traditional method of microinjecting CRISPR material into insect embryos. The adoption of advanced gene-editing technologies is contributing to the efficiency and precision of genetic modifications.

Major companies operating in the genome editing or genome engineering market are engaging in strategic partnerships to fortify their positions. Strategic partnerships, such as the collaboration between Ionis Pharmaceuticals Inc. and Metagenomi, aim to expand and diversify technological capabilities. Ionis Pharmaceuticals Inc., a biotechnology company, partnered with Metagenomi, a genomic medicines company, to leverage their respective technologies and deliver transformative therapies focused on genetic targets. Such collaborations enable companies to pool resources, share expertise, and innovate collectively, fostering advancements in the genome editing or genome engineering field.

In September 2022, Lesaffre, a France-based microorganisms, healthcare and biotechnology company acquired Recombia Biosciences for an undisclosed amount. The acquisition aims to leverage Recombia Biosciences' genome-editing technologies and accelerate the development of yeasts for sustainable production of fermented ingredients. Recombia Biosciences is a US-based biotechnology company.

Major companies operating in the genome editing or genome engineering market report are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

North America was the largest region in the gene editing or genome engineering market in 2023. Asia-Pacific is expected to be the fastest-growing region in the genome editing or genome engineering market report during the forecast period. The regions covered in the genome editing or genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genome editing or genome engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genome editing or genome engineering market includes revenues earned by entities through cell line engineering, animal genetic engineering, and plant genetic engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Genome Editing/Genome Engineering Market Characteristics

3. Genome Editing/Genome Engineering Market Trends And Strategies

4. Genome Editing/Genome Engineering Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Genome Editing/Genome Engineering Market Size and Growth

  • 5.1. Global Genome Editing/Genome Engineering Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Genome Editing/Genome Engineering Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Genome Editing/Genome Engineering Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Genome Editing/Genome Engineering Market Segmentation

  • 6.1. Global Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Reagents And Consumables
  • Software And systems
  • Services
  • 6.2. Global Genome Editing/Genome Engineering Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • CRISPR
  • TALEN
  • ZFN
  • Antisense
  • Other Technologies
  • 6.3. Global Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery And Development
  • Other Applications
  • 6.4. Global Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic And Government Research Institutes

7. Genome Editing/Genome Engineering Market Regional And Country Analysis

  • 7.1. Global Genome Editing/Genome Engineering Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Genome Editing/Genome Engineering Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Genome Editing/Genome Engineering Market

  • 8.1. Asia-Pacific Genome Editing/Genome Engineering Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Genome Editing/Genome Engineering Market

  • 9.1. China Genome Editing/Genome Engineering Market Overview
  • 9.2. China Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Genome Editing/Genome Engineering Market

  • 10.1. India Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Genome Editing/Genome Engineering Market

  • 11.1. Japan Genome Editing/Genome Engineering Market Overview
  • 11.2. Japan Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Genome Editing/Genome Engineering Market

  • 12.1. Australia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Genome Editing/Genome Engineering Market

  • 13.1. Indonesia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Genome Editing/Genome Engineering Market

  • 14.1. South Korea Genome Editing/Genome Engineering Market Overview
  • 14.2. South Korea Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Genome Editing/Genome Engineering Market

  • 15.1. Western Europe Genome Editing/Genome Engineering Market Overview
  • 15.2. Western Europe Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Genome Editing/Genome Engineering Market

  • 16.1. UK Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Genome Editing/Genome Engineering Market

  • 17.1. Germany Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Genome Editing/Genome Engineering Market

  • 18.1. France Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Genome Editing/Genome Engineering Market

  • 19.1. Italy Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Genome Editing/Genome Engineering Market

  • 20.1. Spain Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Genome Editing/Genome Engineering Market

  • 21.1. Eastern Europe Genome Editing/Genome Engineering Market Overview
  • 21.2. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Genome Editing/Genome Engineering Market

  • 22.1. Russia Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Genome Editing/Genome Engineering Market

  • 23.1. North America Genome Editing/Genome Engineering Market Overview
  • 23.2. North America Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Genome Editing/Genome Engineering Market

  • 24.1. USA Genome Editing/Genome Engineering Market Overview
  • 24.2. USA Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Genome Editing/Genome Engineering Market

  • 25.1. Canada Genome Editing/Genome Engineering Market Overview
  • 25.2. Canada Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Genome Editing/Genome Engineering Market

  • 26.1. South America Genome Editing/Genome Engineering Market Overview
  • 26.2. South America Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Genome Editing/Genome Engineering Market

  • 27.1. Brazil Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Genome Editing/Genome Engineering Market

  • 28.1. Middle East Genome Editing/Genome Engineering Market Overview
  • 28.2. Middle East Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Genome Editing/Genome Engineering Market

  • 29.1. Africa Genome Editing/Genome Engineering Market Overview
  • 29.2. Africa Genome Editing/Genome Engineering Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Genome Editing/Genome Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Genome Editing/Genome Engineering Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Genome Editing/Genome Engineering Market Competitive Landscape And Company Profiles

  • 30.1. Genome Editing/Genome Engineering Market Competitive Landscape
  • 30.2. Genome Editing/Genome Engineering Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck Group
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Genscript Biotech Corp
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sangamo Therapeutics Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Lonza Group AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Genome Editing/Genome Engineering Market Competitive Benchmarking

32. Global Genome Editing/Genome Engineering Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Genome Editing/Genome Engineering Market

34. Genome Editing/Genome Engineering Market Future Outlook and Potential Analysis

  • 34.1 Genome Editing/Genome Engineering Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Genome Editing/Genome Engineering Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Genome Editing/Genome Engineering Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer